ReShape Lifesciences Inc.
RSLS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$27.51M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $27.51 Million |
|---|---|
| Enterprise Value | $19.66 Million |
| Earnings per Share | $-4.75 |
| Beta | 1.9 |
| Outstanding Shares | 7,018,528 |
Return
| Return on Equity | -161.66% |
|---|---|
| Return on Assets | -106.56% |
| Return on Invested Capital | -134.48% |
Valuation & Multiples
| P/E Ratio | -0.06 |
|---|---|
| PEG | 0.08 |
| Price to Sales | -3.92 |
| Price to Book Ratio | 3.92 |
| Enterprise Value to Revenue | -9.95 |
| Enterprise Value to EBIT | -2 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 18, 2025
EPS Estimate
$-0.11
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Vyome Holdings, Inc.
18 employees
CEO: Venkateswarlu Nelabhotla
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disor...